| Stage | MLR | % of rev | BLBD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $240M | 100.00% | $517M | 100.00% | BLBD ×2.15 |
| Gross profit | $36M | 14.97% | $103M | 19.99% | BLBD +5.0pp |
| Operating income | $10M | 4.34% | $63M | 12.12% | BLBD +7.8pp |
| Pre-tax income | $10M | 4.20% | $197M | 38.10% | BLBD +33.9pp |
| Net income | $7M | 3.03% | $185M | 35.82% | BLBD +32.8pp |
| Stage | MLR | BLBD | Gap · A − B |
|---|---|---|---|
| Revenue | $240M100.00% | $517M100.00% | BLBD ×2.15 |
| Gross profit | 14.97%$36M | 19.99%$103M | BLBD +5.0pp |
| Operating income | 4.34%$10M | 12.12%$63M | BLBD +7.8pp |
| Pre-tax income | 4.20%$10M | 38.10%$197M | BLBD +33.9pp |
| Net income |
| 3.03%$7M |
| 35.82%$185M |
| BLBD +32.8pp |
None
No disclosed counterparties: MLR.